|
Variables
|
5-year cumulative OS
|
5-year cumulative DFS
|
|---|
|
MSD
|
AD
|
MSD
|
AD
|
|---|
|
Grade II-IV aGVHD
|
|
Yes
|
50.0 ± 35.4
|
30.0 ± 17.5
|
50.0 ± 35.4
|
15.0 ± 13.8
|
|
No
|
54.4. ± 9.0
|
78.1 ± 6.7
|
44.4 ± 9.3
|
73.6 ± 7.1
|
|
P-value
|
0.474
|
0.002
|
0.605
|
0.001
|
|
Donor-recipient ABO compatibility
|
|
Compatible
|
66.6 ± 12.8
|
55.6 ± 11.4
|
67.0 ± 12.8
|
50.9 ± 11.6
|
|
Incompatible
|
45.9 ± 11.3
|
83.0. ± 7.1
|
27.7 ± 10.9
|
74.9. ± 8.5
|
|
P-value
|
0.244
|
0.047
|
0.041
|
0.078
|
|
Conditioning regimen
|
|
Bu/Cy-based
|
52.3 ± 10.3
|
77.6 ± 7.1
|
44.1 ± 10.4*
|
69.2 ± 7.9*
|
|
TBI/Cy-based
|
60.8 ± 15.8
|
58.7. ± 13.1
|
40.5 ± 19.6*
|
58.7 ± 13.1*
|
|
P-value
|
0.777
|
0.023
|
0.854
|
0.093
|
|
CMV infection
|
|
Yes
|
44.4 ± 18.9
|
60.9 ± 9.5
|
15.6 ± 14.2*
|
57.4 ± 9.7*
|
|
No
|
57.2 ± 9.7
|
85.0. ± 8.2
|
54 ± 9.8*
|
75 ± 9.9*
|
|
P-value
|
0.748
|
0.033
|
0.235
|
0.083
|
- * Estimated value censored
